Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: A stratified analysis according to underlying diseases and sites of infection in a large prospective cohort

Journal of Infection

Volumn 61, Issue 4, 2010, Pages 299-306

  Kang, Cheol In ^a   Song, Jae Hoon ^a,p   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Ko, Kwan Soo ^a,p   Yeom, Joon Sup ^b   Kim, Shin Woo ^c   Chang, Hyun Ha ^c   Kim, Yeon Sook ^d   Jung, Sook In ^d   Son, Jun Seong ^e   Hsueh, Po Ren ^f   So, Thomas Man kit ^g   Lalitha, M K ^h,s   Yang, Yonghong ⁱ   Huang, Shao Guang ^j   Wang, Hui ^k   Lu, Quan ^l   Carlos, Celia C ^m   Perera, Jennifer A ⁿ   Chiu, Cheng Hsun ^o   Liu, Jien Wei ^o   Chongthaleong, Anan ^p   Thamlikitkul, Visanu ^q   Van Pham, Hung ^r   more..

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g PRINCESS MARGARET HOSPITAL   (Hong Kong)

^h CHRISTIAN MEDICAL COLLEGE   (India)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

^j SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^k PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^l SHANGHAI JIAO TONG UNIVERSITY   (China)

^m RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

ⁿ UNIVERSITY OF COLOMBO   (Sri Lanka)

^o CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^p Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^q MAHIDOL UNIVERSITY   (Thailand)

^r UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^s MADRAS MEDICAL MISSION HOSPITAL   (India)

more..

Author keywords

Infection; Methicillin resistance; Risk factors; Staphylococcus aureus; Treatment outcome

Indexed keywords

METICILLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BONE INFECTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INFECTIOUS ARTHRITIS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PENICILLIN RESISTANCE; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956652604     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.07.011     Document Type: Article

References (22)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
2. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003, 187:1452-1459.
3. Davis S.L., Perri M.B., Donabedian S.M., Manierski C., Singh A., Vager D., et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007, 45:1705-1711.
4. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
5. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
6. Lodise T.P., McKinnon P.S. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005, 52:113-122.
7. Harbarth S., Rutschmann O., Sudre P., Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189.
8. Soriano A., Martinez J.A., Mensa J., Marco F., Almela M., Moreno-Martinez A., et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000, 30:368-373.
9. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Oh M.D., et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis 2004, 39:812-818.
10. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrobial Agents Chemother 2005, 49:760-766.
11. Kim S.H., Park W.B., Lee K.D., Kang C.I., Kim H.B., Oh M.D., et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003, 37:794-799.
12. Roghmann M.C. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000, 160:1001-1004.
13. Selvey L.A., Whitby M., Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?. Infect Control Hosp Epidemiol 2000, 21:645-648.
14. Song JH, Hsueh PR, Ko KS, Kang CI, Chung DR. Nosocomial origin of community-associated methicillin-resistant Staphylococcus aureus in Asian countries: an ANSORP surveillance study. 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008:152.
15. Blot S.I., Vandewoude K.H., Hoste E.A., Colardyn F.A. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162:2229-2235.
16. Combes A., Luyt C.E., Fagon J.Y., Wollf M., Trouillet J.L., Gibert C., et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 2004, 170:786-792.
17. Engemann J.J., Carmeli Y., Cosgrove S.E., Fowler V.G., Bronstein M.Z., Trivette S.L., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598.
18. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
19. Kim S.H., Park W.B., Lee K.D., Kang C.I., Bang J.W., Kim H.B., et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004, 54:489-497.
20. Melzer M., Eykyn S.J., Gransden W.R., Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003, 37:1453-1460.
21. Musher D.M., Alexandraki I., Graviss E.A., Yanbeiy N., Eid A., Inderias L.A., et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000, 79:210-221.
22. Cho J.H., Park K.H., Kim S.H., Bang J.H., Park W.B., Kim H.B., et al. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis 2007, 39:697-702.